PACS Group (NYSE:PACS) CEO Sells $476,226.67 in Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 10,529 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $45.23, for a total value of $476,226.67. Following the completion of the transaction, the chief executive officer directly owned 54,555,566 shares in the company, valued at $2,467,548,250.18. The trade was a 0.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total transaction of $14,274.51.
• On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total transaction of $396,098.36.
• On Wednesday, September 9th, Jason Murray sold 4,758 shares of PACS Group stock. The stock was sold at an average price of $43.33, for a total transaction of $206,164.14.
• On Tuesday, September 8th, Jason Murray sold 24,057 shares of PACS Group stock. The stock was sold at an average price of $43.49, for a total transaction of $1,046,238.93.
• On Friday, September 4th, Jason Murray sold 23,072 shares of PACS Group stock. The shares were sold at an average price of $42.69, for a total transaction of $984,943.68.
• On Thursday, September 3rd, Jason Murray sold 20,173 shares of PACS Group stock. The shares were sold at an average price of $42.56, for a total transaction of $858,562.88.
• On Wednesday, September 2nd, Jason Murray sold 23,783 shares of PACS Group stock. The stock was sold at an average price of $42.94, for a total transaction of $1,021,242.02.
• On Tuesday, September 1st, Jason Murray sold 24,157 shares of PACS Group stock. The stock was sold at an average price of $42.39, for a total transaction of $1,024,015.23.
• On Friday, August 21st, Jason Murray sold 59,244 shares of PACS Group stock. The shares were sold at an average price of $43.90, for a total transaction of $2,600,811.60.
• On Thursday, August 20th, Jason Murray sold 91,306 shares of PACS Group stock. The shares were sold at an average price of $43.92, for a total transaction of $4,010,159.52.

PACS Group Trading Up 1.5%

NYSE:PACS opened at $42.72 on Thursday. PACS Group, Inc. has a one year low of $10.31 and a one year high of $49.49. The business has a fifty day moving average price of $44.69 and a 200-day moving average price of $39.14. The firm has a market capitalization of $6.76 billion, a price-to-earnings ratio of 24.84, a price-to-earnings-growth ratio of 1.31 and a beta of -0.13. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91.

PACS Group (NYSE:PACS) last released its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. Sell-side analysts forecast that PACS Group, Inc. will post 2.13 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on PACS. Royal Bank Of Canada lifted their price objective on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. UBS Group raised their target price on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Weiss Ratings downgraded shares of PACS Group from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, August 5th. Truist Financial set a $62.00 price target on shares of PACS Group in a research note on Wednesday, September 2nd. Finally, Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, PACS Group has an average rating of “Moderate Buy” and an average price target of $58.80.

Institutional Trading of PACS Group

Several hedge funds have recently modified their holdings of PACS. Principal Financial Group Inc. bought a new position in PACS Group during the first quarter valued at $3,171,000. Smith Group Asset Management LLC purchased a new stake in shares of PACS Group during the 1st quarter valued at about $771,000. Maven Securities LTD purchased a new stake in shares of PACS Group during the 4th quarter valued at about $960,000. Bank of New York Mellon Corp bought a new position in shares of PACS Group in the 2nd quarter valued at about $8,196,000. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new position in PACS Group in the first quarter worth about $6,762,000.

PACS Group News Summary

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Management provided updates on PACS Group’s growth strategy, including the Eduro and Florida acquisitions. The company’s focus on expanding its post-acute-care footprint could support future revenue and earnings growth. PACS growth strategy, Eduro and Florida acquisitions
• Positive Sentiment: PACS is reportedly using higher patient volume and mergers and acquisitions to offset managed-care pressures. If successful, the strategy could improve scale and help defend margins in a challenging reimbursement environment. PACS managed-care and M&A strategy
• Positive Sentiment: The latest reported quarter exceeded expectations, with earnings per share of $0.63 versus the $0.54 consensus estimate and revenue of $1.43 billion versus $1.41 billion expected. Analysts’ average price target remains about $58.80, above recent trading levels, with an overall “Moderate Buy” rating.
• Neutral Sentiment: Director Mark Hancock sold 144,318 shares for approximately $6.4 million on September 14 and another 155,682 shares for about $6.6 million on September 15. Both transactions were made under a pre-arranged Rule 10b5-1 plan, and Hancock still owns more than 53.5 million shares, limiting the signal from the sales. Mark Hancock PACS insider sales
• Negative Sentiment: CEO Jason Murray has also continued selling shares, including 317 shares on September 14 and 10,529 shares on September 11, following several larger sales earlier in the month. The transactions were conducted under a 10b5-1 plan, but repeated executive selling may create modest near-term pressure or investor concern. Jason Murray PACS insider sales

PACS Group Company Profile

PACS Group, Inc is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market.